PharmaSGP Holding SE (PSG) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.115x

Based on the latest financial reports, PharmaSGP Holding SE (PSG) has a cash flow conversion efficiency ratio of 0.115x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.22 Million ≈ $4.94 Million USD) by net assets (€36.67 Million ≈ $42.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of PharmaSGP Holding SE to measure how many days the company can operate on defensive assets alone.

PharmaSGP Holding SE - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how PharmaSGP Holding SE's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PharmaSGP Holding SE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PharmaSGP Holding SE ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Xiamen Goldenhome Co Ltd SHG:603180	-0.071x
Gersan Elektrik Ticaret ve Sanayi AS IS:GEREL	-0.369x
Masterwork Machinery SHE:300195	0.014x
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A SHG:600613	0.046x
Zorlu Enerji Elektrik Uretim AS IS:ZOREN	-0.033x
Hibiscus Petroleum BHD KLSE:5199	-0.186x
Galata Wind Enerji Anonim Sirket IS:GWIND	0.046x
Uchi Technologies Bhd KLSE:7100	0.118x

Annual Cash Flow Conversion Efficiency for PharmaSGP Holding SE (2014–2024)

The table below shows the annual cash flow conversion efficiency of PharmaSGP Holding SE from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see PSG company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€31.96 Million ≈ $37.37 Million	€24.88 Million ≈ $29.08 Million	0.778x	+16.15%
2023-12-31	€39.75 Million ≈ $46.48 Million	€26.64 Million ≈ $31.14 Million	0.670x	-15.68%
2022-12-31	€31.10 Million ≈ $36.36 Million	€24.71 Million ≈ $28.89 Million	0.795x	+44.12%
2021-12-31	€22.20 Million ≈ $25.95 Million	€12.24 Million ≈ $14.31 Million	0.551x	-58.95%
2020-12-31	€11.51 Million ≈ $13.45 Million	€15.46 Million ≈ $18.07 Million	1.343x	+628.25%
2019-12-31	€95.58 Million ≈ $111.74 Million	€17.63 Million ≈ $20.61 Million	0.184x	-20.63%
2017-12-31	€61.32 Million ≈ $71.68 Million	€14.25 Million ≈ $16.66 Million	0.232x	+276.99%
2016-12-31	€57.53 Million ≈ $67.26 Million	€3.55 Million ≈ $4.15 Million	0.062x	-68.67%
2015-12-31	€53.79 Million ≈ $62.88 Million	€10.59 Million ≈ $12.38 Million	0.197x	+75.71%
2014-12-31	€48.27 Million ≈ $56.43 Million	€5.41 Million ≈ $6.32 Million	0.112x	--

About PharmaSGP Holding SE

F:PSG Germany

Market Cap

$387.63 Million

€331.56 Million EUR

Market Cap Rank

#14445 Global

#1443 in Germany

Share Price

€28.80

Change (1 day)

+0.70%

52-Week Range

€28.00 - €29.60

All Time High

€32.32